13. Skin
13.8. Sunscreens, camouflagers and photodamage
13.8.1. Sunscreen preparations and photodamage
13.8.1.2. Conditions associated with photodamage
Total Formulary
AFAMELANOTIDE (implant)
Restrictions:
Prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP) is restricted to specialist use.
Prescribing Notes:
- This therapy is available via the Scottish Government Ultra-orphan pathway
- Formulary status will be reconsidered following the reassessment by SMC (expected 2024)


